Mycophenolate Mofetil Tablet 500mg
Description
Mycotrans 500mg Tablets—A Guide to Transplant Medicine
Mycotran 500 Introduction:
Mycotrans 500 mg contains Mycophenolate Mofetil IP 500mg. It is an immunosuppressant, available only through prescription as part of a specialist-led treatment plan, to help prevent organ rejection in certain transplant situations.
It is not an antibiotic or painkiller and does not fight infection. It suppresses certain immune system activity. This decreases the chances of the immune system attacking a transplanted organ.
Overview of Mycotrans 500:
Brand name: Mycotrans 500
Active substance: Mycophenolate mofetil
Composition: Mycophenolate Mofetil IP 500 mg
Strength: Each Tablet contains 500 mg.
Dosage form: Tablet, oral
Medicine group: Immunosuppressive, antimetabolite
Therapeutic sector: Drugs for organ transplantation
Route of Administration: Oral
Mycophenolate Mofetil is used for:
After an organ transplant, the immune system may recognize the transplanted organ as foreign and try to attack it. This is known as organ rejection. Mycophenolate mofetil may be used with other immunosuppressive drugs to help prevent rejection after the following:
-Transplant kidney
-Heart transplant
-Transplantation of liver
Role in Transplant Management:
Mycotrans 500 may be used appropriately with other prescribed immunosuppressants to:
- Help reduce the risk of rejection of transplanted organs;
- Support maintenance immunosuppressive therapy
- Be part of a coordinated kidney/heart/liver transplant program
-Help modulate immune response to the transplanted organ
Dosage: Specialist Supervision is Crucial:
There is not a universally applicable dosage for transplant recipients. The dose is set by the treating specialist based on variables such as
- Which organ was transplanted?
-Size and age of patient
-Kidney and liver tests
-Blood test results
Other immunosuppressants in clinical use:
Response to treatment and side effects
Important Pregnancy Warning
Mycophenolate mofetil has a black box warning for pregnancy. Exposure in pregnancy is associated with first trimester pregnancy loss and congenital abnormalities.
Patients who could become pregnant require medical counselling about pregnancy testing, prevention, and planning before and during treatment. Patients must not stop treatment independently if pregnancy occurs or is suspected; they should contact their transplant specialist immediately.
Possible Side Effects:
Side effects can vary according to the transplant type, dose, and other medicines in the treatment regimen. Possible effects include:
-Diarrhoea
-Nausea or vomiting
-Abdominal discomfort
-Headache
-Reduced white blood-cell count
-Anaemia
-Increased susceptibility to infection
-Weakness or tiredness
Keeping and Handling Mycotrans 500:
Keep the medicine in its original packaging and follow the temperature conditions printed on the approved label. Protect the tablets from moisture, excessive heat, and direct sunlight.
Tablets should not be crushed because damaged tablets may release powder that should not contact the skin or mucous membranes. Keep the product securely away from children and dispose of expired or damaged medicine according to local pharmaceutical-waste procedures.
Frequently Asked Questions:
1. What is Mycotrans 500?
Mycotrans 500 is a prescription immunosuppressant tablet containing Mycophenolate Mofetil IP 500mg.
2. What is Mycotrans 500 used for?
It may be used with other immunosuppressive medicines to help prevent organ rejection after an eligible kidney, heart, or liver transplant.
3. What is the active ingredient in Mycotrans 500?
Its active ingredient is Mycophenolate Mofetil, supplied at a strength of 500mg per tablet.
4. How does Mycophenolate Mofetil work?
It reduces the activity and multiplication of selected immune cells involved in attacking a transplanted organ.
5. How should Mycotrans 500 be taken?
It must be taken exactly as directed by the transplant specialist. The tablet should generally be swallowed whole and should not be crushed.